Clinical Trials in Phoenix

Showing 3821-3840 of 8,495 trials

Formula Tolerance of Term Infants

NCT04915937

To assess the effects of infant formula with oligosaccharides on symptoms of formula intolerance in healthy, term infants

Gastro-Intestinal Tolerance

Abbott Nutrition45 participantsStarted Jul 2021

Phoenix, Arizona, United States • Miami, Florida, United States • Macon, Georgia, United States +9 more locations

TERMINATEDPhase 2< 1 mile

Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer

NCT02978222

This is a double-blind, randomized, parallel groups Phase II trial. Patients with platinum-sensitive advanced ovarian cancer, defined as a lack of progression by RECIST v1.1 criteria following completion of standard-of-care chemotherapy, including a minimum of 4 cycles of a platinum-containing regimen. Patients will be randomized to either the vaccine regimen with GM-CSF adjuvant or GM-CSF adjuvant alone as a control group. Treatment will be administered as a consolidation therapy within one year of the last administration of platinum, targeting the first remission.

Platinum Sensitive Ovarian CancerOvarian Cancer

Marker Therapeutics, Inc.120 participantsStarted Jul 2017

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Newport Beach, California, United States +15 more locations

Formula Tolerance of Term Infants

Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer

Find Trials by Condition in Phoenix

Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial

Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors

A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)

Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants

Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata

Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer

A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)

A Study to Assess the Tolerability and Efficacy of AKST1210 in Patients on Hemodialysis With Cognitive Impairment

A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma